img

Global miRNA Inhibitor Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global miRNA Inhibitor Market Research Report 2024

miRNA inhibitor is a specially designed oligonucleotide molecule that can bind to miRNA and interfere with its natural function, thereby downregulating the expression of target miRNA. MiRNA is a type of small molecule RNA with a length of approximately 22 nucleotides, widely present in eukaryotic cells and capable of regulating gene expression through interactions with targeted mRNA. MiRNA plays an important regulatory role in normal biological processes. However, when the expression of certain miRNAs is abnormal or excessive, it can lead to the emergence and development of many diseases (such as cancer, cardiovascular disease, etc.). Therefore, the regulation and intervention of miRNA has become one of the current research hotspots. MiRNA inhibitors are an artificial intervention method targeting miRNA. MiRNA inhibitors and miRNAs have complementary pairing characteristics, which can specifically bind to the target miRNA and prevent the interaction between miRNA and mRNA, thereby downregulating the expression of the target miRNA. The design of miRNA inhibitors usually uses chemical synthesis techniques, which can optimize their stability, specificity, and biological activity by changing the sequence of the inhibitor, chemical modification, and other methods. The use of miRNA inhibitors can effectively regulate the expression of miRNA. In vitro experiments, after intervention with miRNA inhibitors, the expression level of target miRNAs in cells will significantly decrease, while the corresponding mRNA expression level will also increase. In addition, miRNA inhibitors can also be used for the study and validation of miRNA function, providing important tools for the study of miRNA related mechanisms. MiRNA inhibitors are specially designed molecules that can downregulate the expression of target miRNAs by binding to miRNAs and interfering with their natural functions. The use of miRNA inhibitors is an effective means of miRNA intervention, which is of great significance for the regulation and intervention of miRNA.
According to MRAResearch’s new survey, global miRNA Inhibitor market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033.
Key companies engaged in the miRNA Inhibitor industry include Thermo Fisher, GenePharma, GeneCopoeia, BioPioneer Tech, IDT, QIAGEN, Eurogentec and SwitchGear Genomics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of miRNA Inhibitor were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole miRNA Inhibitor market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global miRNA Inhibitor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Thermo Fisher
GenePharma
GeneCopoeia
BioPioneer Tech
IDT
QIAGEN
Eurogentec
SwitchGear Genomics
Segment by Type
ASOs Inhibitors
Small Molecule Inhibitors

Segment by Application


Biopharmaceutical Companies
Academic and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The miRNA Inhibitor report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global miRNA Inhibitor Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 ASOs Inhibitors
1.2.3 Small Molecule Inhibitors
1.3 Market by Application
1.3.1 Global miRNA Inhibitor Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global miRNA Inhibitor Market Perspective (2018-2033)
2.2 miRNA Inhibitor Growth Trends by Region
2.2.1 Global miRNA Inhibitor Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 miRNA Inhibitor Historic Market Size by Region (2018-2023)
2.2.3 miRNA Inhibitor Forecasted Market Size by Region (2024-2033)
2.3 miRNA Inhibitor Market Dynamics
2.3.1 miRNA Inhibitor Industry Trends
2.3.2 miRNA Inhibitor Market Drivers
2.3.3 miRNA Inhibitor Market Challenges
2.3.4 miRNA Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top miRNA Inhibitor Players by Revenue
3.1.1 Global Top miRNA Inhibitor Players by Revenue (2018-2023)
3.1.2 Global miRNA Inhibitor Revenue Market Share by Players (2018-2023)
3.2 Global miRNA Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by miRNA Inhibitor Revenue
3.4 Global miRNA Inhibitor Market Concentration Ratio
3.4.1 Global miRNA Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by miRNA Inhibitor Revenue in 2022
3.5 miRNA Inhibitor Key Players Head office and Area Served
3.6 Key Players miRNA Inhibitor Product Solution and Service
3.7 Date of Enter into miRNA Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 miRNA Inhibitor Breakdown Data by Type
4.1 Global miRNA Inhibitor Historic Market Size by Type (2018-2023)
4.2 Global miRNA Inhibitor Forecasted Market Size by Type (2024-2033)
5 miRNA Inhibitor Breakdown Data by Application
5.1 Global miRNA Inhibitor Historic Market Size by Application (2018-2023)
5.2 Global miRNA Inhibitor Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America miRNA Inhibitor Market Size (2018-2033)
6.2 North America miRNA Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America miRNA Inhibitor Market Size by Country (2018-2023)
6.4 North America miRNA Inhibitor Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe miRNA Inhibitor Market Size (2018-2033)
7.2 Europe miRNA Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe miRNA Inhibitor Market Size by Country (2018-2023)
7.4 Europe miRNA Inhibitor Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific miRNA Inhibitor Market Size (2018-2033)
8.2 Asia-Pacific miRNA Inhibitor Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific miRNA Inhibitor Market Size by Region (2018-2023)
8.4 Asia-Pacific miRNA Inhibitor Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America miRNA Inhibitor Market Size (2018-2033)
9.2 Latin America miRNA Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America miRNA Inhibitor Market Size by Country (2018-2023)
9.4 Latin America miRNA Inhibitor Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa miRNA Inhibitor Market Size (2018-2033)
10.2 Middle East & Africa miRNA Inhibitor Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa miRNA Inhibitor Market Size by Country (2018-2023)
10.4 Middle East & Africa miRNA Inhibitor Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher miRNA Inhibitor Introduction
11.1.4 Thermo Fisher Revenue in miRNA Inhibitor Business (2018-2023)
11.1.5 Thermo Fisher Recent Development
11.2 GenePharma
11.2.1 GenePharma Company Detail
11.2.2 GenePharma Business Overview
11.2.3 GenePharma miRNA Inhibitor Introduction
11.2.4 GenePharma Revenue in miRNA Inhibitor Business (2018-2023)
11.2.5 GenePharma Recent Development
11.3 GeneCopoeia
11.3.1 GeneCopoeia Company Detail
11.3.2 GeneCopoeia Business Overview
11.3.3 GeneCopoeia miRNA Inhibitor Introduction
11.3.4 GeneCopoeia Revenue in miRNA Inhibitor Business (2018-2023)
11.3.5 GeneCopoeia Recent Development
11.4 BioPioneer Tech
11.4.1 BioPioneer Tech Company Detail
11.4.2 BioPioneer Tech Business Overview
11.4.3 BioPioneer Tech miRNA Inhibitor Introduction
11.4.4 BioPioneer Tech Revenue in miRNA Inhibitor Business (2018-2023)
11.4.5 BioPioneer Tech Recent Development
11.5 IDT
11.5.1 IDT Company Detail
11.5.2 IDT Business Overview
11.5.3 IDT miRNA Inhibitor Introduction
11.5.4 IDT Revenue in miRNA Inhibitor Business (2018-2023)
11.5.5 IDT Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Detail
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN miRNA Inhibitor Introduction
11.6.4 QIAGEN Revenue in miRNA Inhibitor Business (2018-2023)
11.6.5 QIAGEN Recent Development
11.7 Eurogentec
11.7.1 Eurogentec Company Detail
11.7.2 Eurogentec Business Overview
11.7.3 Eurogentec miRNA Inhibitor Introduction
11.7.4 Eurogentec Revenue in miRNA Inhibitor Business (2018-2023)
11.7.5 Eurogentec Recent Development
11.8 SwitchGear Genomics
11.8.1 SwitchGear Genomics Company Detail
11.8.2 SwitchGear Genomics Business Overview
11.8.3 SwitchGear Genomics miRNA Inhibitor Introduction
11.8.4 SwitchGear Genomics Revenue in miRNA Inhibitor Business (2018-2023)
11.8.5 SwitchGear Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global miRNA Inhibitor Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of ASOs Inhibitors
Table 3. Key Players of Small Molecule Inhibitors
Table 4. Global miRNA Inhibitor Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global miRNA Inhibitor Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global miRNA Inhibitor Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global miRNA Inhibitor Market Share by Region (2018-2023)
Table 8. Global miRNA Inhibitor Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global miRNA Inhibitor Market Share by Region (2024-2033)
Table 10. miRNA Inhibitor Market Trends
Table 11. miRNA Inhibitor Market Drivers
Table 12. miRNA Inhibitor Market Challenges
Table 13. miRNA Inhibitor Market Restraints
Table 14. Global miRNA Inhibitor Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global miRNA Inhibitor Market Share by Players (2018-2023)
Table 16. Global Top miRNA Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in miRNA Inhibitor as of 2022)
Table 17. Ranking of Global Top miRNA Inhibitor Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by miRNA Inhibitor Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players miRNA Inhibitor Product Solution and Service
Table 21. Date of Enter into miRNA Inhibitor Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global miRNA Inhibitor Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global miRNA Inhibitor Revenue Market Share by Type (2018-2023)
Table 25. Global miRNA Inhibitor Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global miRNA Inhibitor Revenue Market Share by Type (2024-2033)
Table 27. Global miRNA Inhibitor Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global miRNA Inhibitor Revenue Market Share by Application (2018-2023)
Table 29. Global miRNA Inhibitor Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global miRNA Inhibitor Revenue Market Share by Application (2024-2033)
Table 31. North America miRNA Inhibitor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America miRNA Inhibitor Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America miRNA Inhibitor Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe miRNA Inhibitor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe miRNA Inhibitor Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe miRNA Inhibitor Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific miRNA Inhibitor Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific miRNA Inhibitor Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific miRNA Inhibitor Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America miRNA Inhibitor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America miRNA Inhibitor Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America miRNA Inhibitor Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa miRNA Inhibitor Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa miRNA Inhibitor Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa miRNA Inhibitor Market Size by Country (2024-2033) & (US$ Million)
Table 46. Thermo Fisher Company Detail
Table 47. Thermo Fisher Business Overview
Table 48. Thermo Fisher miRNA Inhibitor Product
Table 49. Thermo Fisher Revenue in miRNA Inhibitor Business (2018-2023) & (US$ Million)
Table 50. Thermo Fisher Recent Development
Table 51. GenePharma Company Detail
Table 52. GenePharma Business Overview
Table 53. GenePharma miRNA Inhibitor Product
Table 54. GenePharma Revenue in miRNA Inhibitor Business (2018-2023) & (US$ Million)
Table 55. GenePharma Recent Development
Table 56. GeneCopoeia Company Detail
Table 57. GeneCopoeia Business Overview
Table 58. GeneCopoeia miRNA Inhibitor Product
Table 59. GeneCopoeia Revenue in miRNA Inhibitor Business (2018-2023) & (US$ Million)
Table 60. GeneCopoeia Recent Development
Table 61. BioPioneer Tech Company Detail
Table 62. BioPioneer Tech Business Overview
Table 63. BioPioneer Tech miRNA Inhibitor Product
Table 64. BioPioneer Tech Revenue in miRNA Inhibitor Business (2018-2023) & (US$ Million)
Table 65. BioPioneer Tech Recent Development
Table 66. IDT Company Detail
Table 67. IDT Business Overview
Table 68. IDT miRNA Inhibitor Product
Table 69. IDT Revenue in miRNA Inhibitor Business (2018-2023) & (US$ Million)
Table 70. IDT Recent Development
Table 71. QIAGEN Company Detail
Table 72. QIAGEN Business Overview
Table 73. QIAGEN miRNA Inhibitor Product
Table 74. QIAGEN Revenue in miRNA Inhibitor Business (2018-2023) & (US$ Million)
Table 75. QIAGEN Recent Development
Table 76. Eurogentec Company Detail
Table 77. Eurogentec Business Overview
Table 78. Eurogentec miRNA Inhibitor Product
Table 79. Eurogentec Revenue in miRNA Inhibitor Business (2018-2023) & (US$ Million)
Table 80. Eurogentec Recent Development
Table 81. SwitchGear Genomics Company Detail
Table 82. SwitchGear Genomics Business Overview
Table 83. SwitchGear Genomics miRNA Inhibitor Product
Table 84. SwitchGear Genomics Revenue in miRNA Inhibitor Business (2018-2023) & (US$ Million)
Table 85. SwitchGear Genomics Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global miRNA Inhibitor Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global miRNA Inhibitor Market Share by Type: 2022 VS 2033
Figure 3. ASOs Inhibitors Features
Figure 4. Small Molecule Inhibitors Features
Figure 5. Global miRNA Inhibitor Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global miRNA Inhibitor Market Share by Application: 2022 VS 2033
Figure 7. Biopharmaceutical Companies Case Studies
Figure 8. Academic and Research Institutes Case Studies
Figure 9. miRNA Inhibitor Report Years Considered
Figure 10. Global miRNA Inhibitor Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global miRNA Inhibitor Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global miRNA Inhibitor Market Share by Region: 2022 VS 2033
Figure 13. Global miRNA Inhibitor Market Share by Players in 2022
Figure 14. Global Top miRNA Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in miRNA Inhibitor as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by miRNA Inhibitor Revenue in 2022
Figure 16. North America miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America miRNA Inhibitor Market Share by Country (2018-2033)
Figure 18. United States miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe miRNA Inhibitor Market Share by Country (2018-2033)
Figure 22. Germany miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific miRNA Inhibitor Market Share by Region (2018-2033)
Figure 30. China miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America miRNA Inhibitor Market Share by Country (2018-2033)
Figure 38. Mexico miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa miRNA Inhibitor Market Share by Country (2018-2033)
Figure 42. Turkey miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia miRNA Inhibitor Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Thermo Fisher Revenue Growth Rate in miRNA Inhibitor Business (2018-2023)
Figure 45. GenePharma Revenue Growth Rate in miRNA Inhibitor Business (2018-2023)
Figure 46. GeneCopoeia Revenue Growth Rate in miRNA Inhibitor Business (2018-2023)
Figure 47. BioPioneer Tech Revenue Growth Rate in miRNA Inhibitor Business (2018-2023)
Figure 48. IDT Revenue Growth Rate in miRNA Inhibitor Business (2018-2023)
Figure 49. QIAGEN Revenue Growth Rate in miRNA Inhibitor Business (2018-2023)
Figure 50. Eurogentec Revenue Growth Rate in miRNA Inhibitor Business (2018-2023)
Figure 51. SwitchGear Genomics Revenue Growth Rate in miRNA Inhibitor Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries